KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) FCF Margin (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed FCF Margin for 13 consecutive years, with 116.95% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 9757.0% to 116.95% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 66.12% through Dec 2025, down 3674.0% year-over-year, with the annual reading at 66.12% for FY2025, 3674.0% down from the prior year.
  • FCF Margin hit 116.95% in Q4 2025 for ClearPoint Neuro, down from 36.96% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 14.91% in Q3 2024 to a low of 116.95% in Q4 2025.
  • Historically, FCF Margin has averaged 63.33% across 5 years, with a median of 67.39% in 2021.
  • Biggest five-year swings in FCF Margin: surged 5682bps in 2024 and later tumbled -9757bps in 2025.
  • Year by year, FCF Margin stood at 83.84% in 2021, then grew by 28bps to 59.99% in 2022, then skyrocketed by 71bps to 17.47% in 2023, then fell by -11bps to 19.38% in 2024, then tumbled by -503bps to 116.95% in 2025.
  • Business Quant data shows FCF Margin for CLPT at 116.95% in Q4 2025, 36.96% in Q3 2025, and 28.68% in Q2 2025.